348 related articles for article (PubMed ID: 25450553)
41. pH and near-infrared active; chitosan-coated halloysite nanotubes loaded with curcumin-Au hybrid nanoparticles for cancer drug delivery.
Rao KM; Kumar A; Suneetha M; Han SS
Int J Biol Macromol; 2018 Jun; 112():119-125. PubMed ID: 29378273
[TBL] [Abstract][Full Text] [Related]
42. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
43. Stabilization of chitosan/hyaluronan colloidal polyelectrolyte complexes in physiological conditions.
Wu D; Delair T
Carbohydr Polym; 2015 Mar; 119():149-58. PubMed ID: 25563955
[TBL] [Abstract][Full Text] [Related]
44. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
Liu P; Zhao X
Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
[TBL] [Abstract][Full Text] [Related]
45. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
[TBL] [Abstract][Full Text] [Related]
46. Skin targeting by chitosan/hyaluronate hybrid nanoparticles for the management of irritant contact dermatitis: In vivo therapeutic efficiency in mouse-ear dermatitis model.
Abuelella KE; Abd-Allah H; Soliman SM; Abdel-Mottaleb MMA
Int J Biol Macromol; 2023 Mar; 232():123458. PubMed ID: 36709804
[TBL] [Abstract][Full Text] [Related]
47. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
48. Bioactive polyelectrolyte multilayers: hyaluronic acid mediated B lymphocyte adhesion.
Vasconcellos FC; Swiston AJ; Beppu MM; Cohen RE; Rubner MF
Biomacromolecules; 2010 Sep; 11(9):2407-14. PubMed ID: 20795701
[TBL] [Abstract][Full Text] [Related]
49. pH-responsive hyaluronic acid-based nanoparticles for targeted curcumin delivery and enhanced cancer therapy.
Lai H; Ding X; Ye J; Deng J; Cui S
Colloids Surf B Biointerfaces; 2021 Feb; 198():111455. PubMed ID: 33243547
[TBL] [Abstract][Full Text] [Related]
50. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
51. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery.
Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD
Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066
[TBL] [Abstract][Full Text] [Related]
52. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
53. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Xiao B; Han MK; Viennois E; Wang L; Zhang M; Si X; Merlin D
Nanoscale; 2015 Nov; 7(42):17745-55. PubMed ID: 26455329
[TBL] [Abstract][Full Text] [Related]
54. Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
Umerska A; Paluch KJ; Inkielewicz-Stępniak I; Santos-Martinez MJ; Corrigan OI; Medina C; Tajber L
Int J Pharm; 2012 Oct; 436(1-2):75-87. PubMed ID: 22814226
[TBL] [Abstract][Full Text] [Related]
55. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
56. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery.
Almalik A; Day PJ; Tirelli N
Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105
[TBL] [Abstract][Full Text] [Related]
57. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N
J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813
[TBL] [Abstract][Full Text] [Related]
58. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
59. Physico-chemical characterization and cytotoxicity evaluation of curcumin loaded in chitosan/chondroitin sulfate nanoparticles.
Jardim KV; Joanitti GA; Azevedo RB; Parize AL
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():294-304. PubMed ID: 26249593
[TBL] [Abstract][Full Text] [Related]
60. Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis.
Chen YN; Hsu SL; Liao MY; Liu YT; Lai CH; Chen JF; Nguyen MT; Su YH; Chen ST; Wu LC
Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28029125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
